Nutex Health Inc.
NUTX
$176.00
$7.584.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 236.03% | 187.10% | 141.25% | 93.80% | 26.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 236.03% | 187.10% | 141.25% | 93.80% | 26.02% |
| Cost of Revenue | 104.49% | 78.14% | 49.31% | 35.56% | 4.31% |
| Gross Profit | 549.94% | 500.74% | 460.45% | 311.02% | 150.48% |
| SG&A Expenses | 349.01% | 363.36% | 144.97% | 62.14% | 37.00% |
| Depreciation & Amortization | 12.24% | 13.47% | 11.77% | 7.84% | 13.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 135.32% | 113.53% | 60.11% | 37.45% | 8.88% |
| Operating Income | 1,201.38% | 1,327.75% | 4,847.08% | 10,768.43% | 347.46% |
| Income Before Tax | 1,208.89% | 731.67% | 543.99% | 326.49% | -10.90% |
| Income Tax Expenses | 2,139.76% | 2,129.03% | 1,030.34% | 396.44% | 1,189.75% |
| Earnings from Continuing Operations | 912.29% | 635.11% | 494.54% | 318.33% | -22.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,535.26% | -1,167.62% | -1,730.39% | -1,707.50% | -242.18% |
| Net Income | 393.11% | 248.71% | 279.69% | 213.78% | -42.23% |
| EBIT | 1,201.38% | 1,327.75% | 4,847.08% | 10,768.43% | 347.46% |
| EBITDA | 725.98% | 643.68% | 968.43% | 861.67% | 813.03% |
| EPS Basic | 322.77% | 222.29% | 243.04% | 192.65% | -50.40% |
| Normalized Basic EPS | 1,260.92% | 473.53% | 446.92% | 285.87% | 77.73% |
| EPS Diluted | 305.44% | 209.90% | 231.56% | 187.71% | -44.34% |
| Normalized Diluted EPS | 1,139.64% | 413.05% | 416.14% | 274.88% | 77.73% |
| Average Basic Shares Outstanding | 23.23% | 19.01% | 17.22% | 15.94% | 5.91% |
| Average Diluted Shares Outstanding | 32.85% | 26.39% | 24.85% | 17.86% | 5.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 6.22% | 11.30% | 3.51% | 1.16% | 0.87% |